Reply to N. Cerveira et al

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical oncology 2019-01, Vol.37 (1), p.90-91
Hauptverfasser: Berman, Ellin, Druker, Brian J, Burwick, Richard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 91
container_issue 1
container_start_page 90
container_title Journal of clinical oncology
container_volume 37
creator Berman, Ellin
Druker, Brian J
Burwick, Richard
description
doi_str_mv 10.1200/JCO.18.01004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2133433090</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2133433090</sourcerecordid><originalsourceid>FETCH-LOGICAL-c163t-d0f9ef69db679ed0284a917a38cb4225c3c1670bbbe4b8a6fa87433d1b2c9e1e3</originalsourceid><addsrcrecordid>eNo9kM9Lw0AQhRdRbK3ePHmQHD2YOLOTZHePEvxJsSAK3pbdZAKV1NRsIvS_N9rqaS7fvMf7hDhFSFACXD0WiwR1AgiQ7okpZlLFSmXZvpiCIhmjpreJOArhHQBTTdmhmBCkUioyU3H2zOtmE_Vt9JREBXdfvOxcxH3kmmNxULsm8MnuzsTr7c1LcR_PF3cPxfU8LjGnPq6gNlznpvK5MlyB1KkzqBzp0o8tWUkjp8B7z6nXLq-dVilRhV6WhpFpJi62ueuu_Rw49Ha1DCU3jfvgdghWItH4AAZG9HKLll0bQse1XXfLles2FsH-2LCjDYva_toY8fNd8uBXXP3Df_PpGymgV0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2133433090</pqid></control><display><type>article</type><title>Reply to N. Cerveira et al</title><source>MEDLINE</source><source>American Society of Clinical Oncology Online Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Berman, Ellin ; Druker, Brian J ; Burwick, Richard</creator><creatorcontrib>Berman, Ellin ; Druker, Brian J ; Burwick, Richard</creatorcontrib><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/JCO.18.01004</identifier><identifier>PMID: 30422739</identifier><language>eng</language><publisher>United States</publisher><subject>Female ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive ; Pregnancy ; Protein-Tyrosine Kinases - antagonists &amp; inhibitors</subject><ispartof>Journal of clinical oncology, 2019-01, Vol.37 (1), p.90-91</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c163t-d0f9ef69db679ed0284a917a38cb4225c3c1670bbbe4b8a6fa87433d1b2c9e1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3716,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30422739$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berman, Ellin</creatorcontrib><creatorcontrib>Druker, Brian J</creatorcontrib><creatorcontrib>Burwick, Richard</creatorcontrib><title>Reply to N. Cerveira et al</title><title>Journal of clinical oncology</title><addtitle>J Clin Oncol</addtitle><subject>Female</subject><subject>Humans</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive</subject><subject>Pregnancy</subject><subject>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM9Lw0AQhRdRbK3ePHmQHD2YOLOTZHePEvxJsSAK3pbdZAKV1NRsIvS_N9rqaS7fvMf7hDhFSFACXD0WiwR1AgiQ7okpZlLFSmXZvpiCIhmjpreJOArhHQBTTdmhmBCkUioyU3H2zOtmE_Vt9JREBXdfvOxcxH3kmmNxULsm8MnuzsTr7c1LcR_PF3cPxfU8LjGnPq6gNlznpvK5MlyB1KkzqBzp0o8tWUkjp8B7z6nXLq-dVilRhV6WhpFpJi62ueuu_Rw49Ha1DCU3jfvgdghWItH4AAZG9HKLll0bQse1XXfLles2FsH-2LCjDYva_toY8fNd8uBXXP3Df_PpGymgV0A</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Berman, Ellin</creator><creator>Druker, Brian J</creator><creator>Burwick, Richard</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190101</creationdate><title>Reply to N. Cerveira et al</title><author>Berman, Ellin ; Druker, Brian J ; Burwick, Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c163t-d0f9ef69db679ed0284a917a38cb4225c3c1670bbbe4b8a6fa87433d1b2c9e1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Female</topic><topic>Humans</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive</topic><topic>Pregnancy</topic><topic>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berman, Ellin</creatorcontrib><creatorcontrib>Druker, Brian J</creatorcontrib><creatorcontrib>Burwick, Richard</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berman, Ellin</au><au>Druker, Brian J</au><au>Burwick, Richard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply to N. Cerveira et al</atitle><jtitle>Journal of clinical oncology</jtitle><addtitle>J Clin Oncol</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>37</volume><issue>1</issue><spage>90</spage><epage>91</epage><pages>90-91</pages><issn>0732-183X</issn><eissn>1527-7755</eissn><cop>United States</cop><pmid>30422739</pmid><doi>10.1200/JCO.18.01004</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0732-183X
ispartof Journal of clinical oncology, 2019-01, Vol.37 (1), p.90-91
issn 0732-183X
1527-7755
language eng
recordid cdi_proquest_miscellaneous_2133433090
source MEDLINE; American Society of Clinical Oncology Online Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Pregnancy
Protein-Tyrosine Kinases - antagonists & inhibitors
title Reply to N. Cerveira et al
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T13%3A49%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply%20to%20N.%20Cerveira%20et%20al&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=Berman,%20Ellin&rft.date=2019-01-01&rft.volume=37&rft.issue=1&rft.spage=90&rft.epage=91&rft.pages=90-91&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/JCO.18.01004&rft_dat=%3Cproquest_cross%3E2133433090%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2133433090&rft_id=info:pmid/30422739&rfr_iscdi=true